Nanobiotix S.A.
NBTX
$51.50
-$3.57-6.48%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 62.62% | 25.15% | -54.61% | -62.85% | -71.79% |
| Total Depreciation and Amortization | -3.89% | -0.13% | 5.17% | 4.63% | 6.91% |
| Total Amortization of Deferred Charges | 6.98% | 400.00% | -- | -- | -- |
| Total Other Non-Cash Items | -121.93% | -84.34% | 4.54% | 59.72% | 107.05% |
| Change in Net Operating Assets | -126.48% | -100.34% | -77.43% | -32.51% | 43.96% |
| Cash from Operations | -78.28% | -217.03% | -2,943.85% | -268.17% | -57.07% |
| Capital Expenditure | 32.62% | 20.12% | -3.09% | -63.14% | -158.21% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 61.19% | -8.93% | -292.11% | -343.07% | -417.54% |
| Cash from Investing | 35.88% | 17.40% | -18.68% | -78.97% | -173.96% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -14.18% | -15.64% | -17.18% | -13.84% | -10.36% |
| Issuance of Common Stock | -- | -97.45% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -135.51% | 72.47% | 92.91% | 91.45% | 89.97% |
| Cash from Financing | 889.50% | -13.51% | -111.54% | -111.13% | -110.97% |
| Foreign Exchange rate Adjustments | -524.51% | -930.21% | -4,892.45% | -764.13% | 283.73% |
| Miscellaneous Cash Flow Adjustments | -- | -200.00% | -210.00% | -200.00% | -- |
| Net Change in Cash | 118.24% | -275.86% | -184.38% | -179.57% | -175.26% |